Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tay-Sachs disease]

A Tanaka1

  • 1Department of Pediatrics, Osaka City University, School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|September 1, 1993
PubMed
Summary
This summary is machine-generated.

GM2-gangliosidosis, including Tay-Sachs disease, results from genetic defects causing GM2-ganglioside accumulation. Mutations in specific genes lead to varied neurological disorder severity and phenotypes across different populations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peroxisomal acetoacetyl-CoA thiolase of an n-alkane-utilizing yeast, Candida tropicalis.

European journal of biochemistry·1992
Same author

Isolation and characterization of cDNAs from BamHI-H gene family RNAs associated with the tumorigenicity of Marek's disease virus.

Journal of virology·1992
Same author

Studies on antiplatelet agents. I. Synthesis and platelet inhibitory activity of 5-alkyl-2-aryl-4-pyridylimidazoles.

Chemical & pharmaceutical bulletin·1992
Same author

Physiological roles of acetoacetyl-CoA thiolase in n-alkane-utilizable yeast, Candida tropicalis: possible contribution to alkane degradation and sterol biosynthesis.

Journal of biochemistry·1992
Same author

Analyses of the risk and operative stress for donors in living-related partial liver transplantation.

Transplantation·1992
Same author

Cloning and characterization of the secY gene from the cyanobacterium Synechococcus PCC7942.

Biochimica et biophysica acta·1992
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Area of Science:

  • Biochemistry
  • Genetics
  • Neuroscience

Context:

  • GM2-gangliosidosis encompasses neurological disorders due to defective GM2-ganglioside catabolism.
  • Three main types exist: B (Tay-Sachs), O (Sandhoff), and AB variants.
  • Genetic defects involve beta-hexosaminidase subunits or the GM2-activator protein.

Purpose:

  • To detail genetic abnormalities causing GM2-gangliosidosis, particularly Tay-Sachs disease.
  • To correlate specific gene mutations with clinical phenotypes and disease severity.
  • To explore ethnic variations in mutation frequencies.

Summary:

  • Identified gene abnormalities in Tay-Sachs disease link beta-hexosaminidase alpha gene defects to clinical outcomes.
  • Severe infantile Tay-Sachs disease involves absent/unstable mRNA or inactive polypeptides.

Related Experiment Videos

  • Specific mutations, like G-to-T at intron 5's 3'-end in Japanese patients, cause exon skipping and inactive proteins.
  • Milder adult forms may involve mutations like Gly269-to-Ser, allowing some active enzyme formation.
  • Certain mutations are prevalent in specific ethnic groups, such as Ashkenazi Jewish and French Canadian populations.

    • Impact:

    • Advances understanding of the molecular basis of Tay-Sachs disease and related disorders.
    • Provides insights into genotype-phenotype correlations in neurological genetic diseases.
    • Highlights the importance of ethnic background in genetic disease presentation and research.